Linda Bolin

Linda Bolin is the Global Labelling Strategy Director at AstraZeneca, where they apply extensive regulatory experience gained from roles in both marketing and research and development across various therapeutic areas. Previously, Linda served as a Clinical Project Manager at AstraZeneca R&D and managed regulatory affairs for multiple product lines over a span of years. Linda has notably led global regulatory efforts in paediatrics, resulting in an invitation to present at the Swedish Pharmaceutical Congress in 2011. They hold a Bachelor of Science in Pharmacy from Uppsala University, which they completed in 1998.